# Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery

> **NCT03071913** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 54 (actual)

## Conditions studied

- Central Nervous System Neoplasm
- Localized Brain Neoplasm
- Metastatic Malignant Neoplasm in the Brain
- Recurrent Brain Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT03071913
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-20
- **Primary completion:** 2023-01-11
- **Final completion:** 2023-01-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2024-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03071913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03071913, "Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03071913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*